Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What is the Anticipated CAGR of the Multiplex PCR Assays Market, and What Factors Will Drive It?

In recent times, there has been a significant expansion in the market size of multiplex pcr assays. The market, valued at $1.51 billion in 2024, is projected to increase to $1.7 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 12.8%. Factors contributing to growth during the historical period include a surge in infectious diseases, heightened government funding and support, increased application in clinical diagnostics, a spike in genetic testing and personalized medicine, enhanced usage in academic and research organizations, advancements in bioinformatics and data examination tools, and a rise in healthcare spending.

The market size for multiplex pcr assays is forecasted to experience significant growth in the upcoming years, with an expected value of $2.8 billion in 2029 and a compound annual growth rate (CAGR) of 13.3%. This anticipated growth through the forecast period can be linked to the broadening of application areas, increasing demand for point-of-care diagnostics, the rise of personalized medicine, the growth in research and development spending, enhanced health consciousness and proactive healthcare, a concentrated focus on precision medicine, along with increasing demand for fast and trustworthy diagnostic tests. Emerging trends during this forecast period include the integration of next-generation sequencing (NGS), partner diagnostics, digital PCR technology, automation, and high-yield systems, point-of-care and handheld devices, customization and multiplexing capabilities, applications of artificial intelligence and machine learning, improved data management, and cloud-based solutions.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18681&type=smp

Which Factors and External Forces Are Driving Demand in the Multiplex PCR Assays Market?

The surge in need for diagnostic testing is anticipated to accelerate the expansion of the multiplex PCR assay market. Diagnostic testing encompasses procedures or tests utilized to confirm or rule out the existence of a disease or condition in a patient. The escalating demand is triggered by the rise in chronic ailments such as cancer and diabetes, which necessitate precise and early detection for successful management. Also, the emphasis on preventive healthcare spurs consistent examinations to identify potential ailments prematurely. Multiplex PCR assays cater for concurrent detection and analysis of several pathogens or genetic markers from an individual sample, bolstering the completeness and effectiveness of diagnostic examinations. For example, in July 2024, as per the National Health Service (NHS), a healthcare provider and hospital based in the U.K., there was an exceedance of diagnostic activity beyond pre-pandemic levels in 2023, witnessing a 21% surge in tests executed in May 2024 compared to the prior year. Furthermore, during May 2024, around 2.4 million diagnostic tests were administered. Hence, the surge in need for diagnostic examinations will boost the expansion of the multiplex PCR assay market.

Which Segments in the Multiplex PCR Assays Offer the Most Growth?

The multiplex pcr assaysmarket covered in this report is segmented –

1) By Assay Type: Planar Assay, Bead Based Assay

2) By Product And Services: Consumables, Instruments, Software And Services

3) By Application: Disease Diagnosis, Research And Development, Other Applications

4) By End User: Biopharmaceutical Companies, Clinical Research Organizations, Academic Research Institutes, Diagnostic Centers, Other End Users

Subsegments:

1) By Planar Assay: Microarray-Based Assays, Dna Chip-Based Assays

2) By Bead Based Assay: Luminex Xmap Assays, Magpix Assays, Flow Cytometry-Based Bead Assays

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=18681&type=smp

What Are the Fastest-Growing Geographies in the #Which Factors and External Forces Are Driving Demand in the Multiplex PCR Assays Market?# Market?

North America was the largest region in the multiplex PCR assays market in 2024. The regions covered in the multiplex PCR assays market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which Cutting-Edge Market Trends Are Expected to Drive theMultiplex PCR Assays Market’s Growth?

The focus of leading businesses in the multiplex PCR assays market is on employing automation, such as next-generation quantitative PCR (qPCR) systems, to offer accurate and adaptable nucleic acid quantification for sophisticated clinical diagnosis and public health improvement. The next-generation qPCR systems can carry out high-throughput, precise and concurrent detection of various targets, thereby enhancing diagnostic precision and efficacy. As an illustration, in November 2023, Roche Diagnostics Corporation, a diagnostic system solutions provider based in Switzerland, introduced the LightCycler PRO System to the market. This state-of-the-art qPCR system supports high-output, accurate, and concurrent detection of diverse targets. It also includes improved temperature uniformity, cutting-edge software, and works seamlessly with over 200 LightMix Modular and 60 CE-IVD assays, boosting diagnostic precision and efficiency. This system serves as an excellent example of how the integration of automation is driving advancements in the multiplex PCR Assays market, thus advancing clinical diagnostics and public health.

View the full report here:

https://www.thebusinessresearchcompany.com/report/multiplex-pcr-assays-global-market-report

What Are the Key Elements That Define the Multiplex PCR Assays Market?

Multiplex PCR assays refer to a type of polymerase chain reaction (PCR) technique that allows simultaneous amplification and detection of multiple DNA or RNA targets within a single reaction. This method enhances efficiency by enabling the analysis of several genetic markers or pathogens in one test, providing comprehensive and cost-effective results.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18681

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model